Successful treatment of calciphylaxis with vitamin K in a patient on haemodialysis

Zainab Wajih, Richard Singer*

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    5 Citations (Scopus)


    Calciphylaxis has high mortality. Vitamin K deficiency is common in haemodialysis patients and may be a trigger for calciphylaxis due to its role in activating a tissue inhibitor of calcification, matrix Gla protein. We report a second case of a female haemodialysis patient who developed calciphylaxis twice and was successfully treated with vitamin K supplementation on both occasions. She did not receive sodium thiosulphate or bisphosphonates nor was there a change made to her dialysis time or prescription. This case highlights how supplementation with vitamin K may improve the outcome of this condition.

    Original languageEnglish
    Pages (from-to)354-356
    Number of pages3
    JournalCKJ: Clinical Kidney Journal
    Issue number2
    Publication statusPublished - 1 Feb 2022


    Dive into the research topics of 'Successful treatment of calciphylaxis with vitamin K in a patient on haemodialysis'. Together they form a unique fingerprint.

    Cite this